JPH3

Chr 16AD

junctophilin 3

Also known as: CAGL237, HDL2, JP-3, JP3, TNRC22

The protein forms junctional membrane complexes that link the plasma membrane with the endoplasmic reticulum in brain neurons, providing structural foundation for cross-talk between cell surface and intracellular calcium release channels. CAG/CTG repeat expansions (40-59 repeats) in the 3' UTR cause Huntington disease-like 2 through a loss-of-function mechanism, inherited in an autosomal dominant pattern. The protein is brain-specific and functions in neurons involved in motor coordination and memory.

OMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
MultiplemechanismADLOEUF 0.201 OMIM phenotype
Clinical SummaryJPH3
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.20LOEUF
pLI 0.999
Z-score 4.29
OE 0.04 (0.010.20)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
-0.32Z-score
OE missense 1.04 (0.971.12)
511 obs / 491.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.04 (0.010.20)
00.351.4
Missense OE1.04 (0.971.12)
00.61.4
Synonymous OE1.43
01.21.6
LoF obs/exp: 1 / 23.4Missense obs/exp: 511 / 491.1Syn Z: -5.09
DN
0.4289th %ile
GOF
0.5072th %ile
LOF
0.76top 10%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · LOEUF 0.20
GOF1 literature citation

Literature Evidence

GOFOur results suggest that the pathogenic mechanism of HDL2 is multifactorial, involving both a toxic gain of function of JPH3 RNA and a toxic loss of JPH3 expression.PMID:22367996

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

JPH3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →